IIR publ. 2000

Written publications

Theses:
Rasmussen ÅK. Cytokine actions on the thyroid gland. Lægeforeningens Forlag. (Thesis). Univ. of Copenhagen, Copenhagen 2000. (with Div. Endocrinol., Rigshospitalet).

Bovin LF. Effekter af membranlipider og intracellulære signalmolekyler på humane leukocytter: Cytokinproduktion, celledeling og programmeret celledød (apoptose) (PhD). Univ. of Copenhagen, Copenhagen 2000.

Petersen AA. Characterisation and clinical relevance of soluble ICAM-1 in multiple sclerosis [Ph.D]. Univ. of Copenhagen, Copenhagen 2000.

Books:

Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors.
Basal og klinisk Immunologi. 3 ed. København: FADL's forlag A/S; 2000. 440 pages.

Chapters in Books:

Andersen V, Wiik A, Mandrup-Poulsen T, Nerup J, Hansen NE, Birgens H, Sørensen PS. Autoimmunsygdomme. In: Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors. Basal og Klinisk immunologi. 3 ed: FADL's forlag A/S; 2000. p. 209-54.

Andersen V, Heilmann C, Dickmeiss E. Immundefekter - AIDS. In: Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors. Basal og Klinisk immunologi. 3 ed: FADL's forlag A/S; 2000. p. 265-82.

Bendtzen K, Haurum JS, Svejgaard A, Ryder LP, Ødum N, Barington T. Celleinteraktioner og regulering. In: Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors. Basal og Klinisk immunologi. 3 ed: FADL's forlag A/S; 2000. p. 67-104.

Bendtzen K, Poulsen LK, Wiik A, Svehag S-E. Immunpatogenese og inflammation. In: Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors. Basal og Klinisk immunologi. 3 ed: FADL's forlag A/S; 2000. p. 151-84.

Bendtzen K, Andersen V, Malling H-J. Immunterapi. In: Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors. Basal og Klinisk immunologi. 3 ed: FADL's forlag A/S; 2000. p. 345-59.

Bendtzen K. Immunologiske metoder. In: Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors. Basal og Klinisk immunologi. 3 ed: FADL's forlag A/S; 2000. p. 371-405.

Werdelin O, Andersen V. Immunsystemets celler og væv. In: Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors. Basal og Klinisk immunologi. 3 ed: FADL's forlag A/S; 1999. p. 7-24.

Peer-reviewed articles:

Andersen LS, Petersen J, Bendtzen K. Production of interleukin (IL)-1b, IL-1 receptor antagonist and IL-10 by mononuclear cells in chronic arthritis. Cytokine 2000;12:62-8. Abstract.

Bendtzen K, Hansen MB, Ross C, Svenson M. Detection of autoantibodies to cytokines. Mol Biotechnol 2000;14:251-61 (Review). Abstract

Bendtzen K, Ross C, Hansen MB, Svenson M. Natural and induced anti-cytokine antibodies. In: Ciliberto G, Savino R, editors. Cytokine inhibitors. New York: Marcel Dekker; 2000. p. 53-95. (Review).

Garred P, Madsen HO, Marquart H, Hansen TM, Sørensen SF, Petersen J, Volck B, Svejgaard A, Graudal NA, Rudd PM, Dwek RA, Sim RB, Andersen V. Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol 2000;27:26-34.

Jess P, Schultz K, Bendtzen K, Nielsen OH. Systemic inflammatory responses during laparoscopic and open inguinal hernia repair: A randomised prospective study. Eur J Surg 2000;166:540-4.

Meyer CN, Svenson M, Larsen CS, Ødum N, Skinhøj P, Bendtzen K. Low prevalence of antibodies and other plasma factors binding to CC chemokines and IL-2 in HIV-positive patients. APMIS 2000;108:122-30. Abstract

Myhr KM, Ross C, Nyland HI, Bendtzen K, Vedeler CA. neutralising antibodies to interferon (IFN) a-2a and interferon b-1a or interferon b-1b in MS are not cross-reactive. Neurology 2000;55:1569-1571. Abstract

Nicoletti F, Di Marco R, Zaccone P, Salvaggio A, Magro G, Bendtzen K, Meroni P. Murine concanavalin A-induced hepatitis is prevented by interleukin (IL)-12 antibody and exacerbated by exogenous IL-12 through an interferon-g-dependent mechanism. Hepatology 2000;32:728-733. Abstract

Nicoletti F, Di Marco R, Conget I, Gomis R, Edwards C 3rd, Papaccio G, Bendtzen K, Sandler S. Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin. J Autoimmunity 2000;15:395-405. Abstract

Papaccio G, Nicoletti F, Pisanti FA, Bendtzen K, Galdieri M. Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells. Endocrinology 2000;141:1500-5. Abstract

Pedersen G, Saermark T, Horn T, Giese B, Bendtzen K, Brynskov J. Cytokine-induced impairment of short-chain fatty acid oxidation and viability in human colonic epithelial cells. Cytokine 2000;12:1400-1404. Abstract

Pedersen G, Saermark T, Bendtzen K, Brynskov J. Cultures of human colonic epithelial cells isolated from endoscopical biopsies from patients with inflammatory bowel disease. Effect of IFN-gamma, TNFa and IL-1b on viability, butyrate oxidation and IL-8 secretion. Autoimmunity 2000; 32:255-263. Abstract

Rasmussen ÅK, Bendtzen K, Feldt-Rasmussen U. Thyrocyte-Interleukin-1 interactions. Exp Clin Endocrinol Diabetes 2000;108:67-71 (Review). Abstract

Rieneck K, Bovin LF, Josefsen K, Buschard K, Svenson M, Bendtzen K. Massive parallel gene expression profiling of RINm5F pancreatic islet b-cells challenged with interleukin-1b. APMIS 2000;108:855-872. Abstract

Ross C, Clemmesen KM, Svenson M, Sorensen PS, Koch-Henriksen N, Skovgaard GL, Bendtzen K. Immunogenicity of interferon-beta in multiple sclerosis patients: influence of preparation, dosage, dose frequency, and route of administration. Danish Multiple Sclerosis Study Group. Ann Neurol 2000;48:706-712. Abstract

Saldeen J, Sandler S, Bendtzen K, Welsh N. Liposome-mediated transfer of IL-1 receptor antagonist gene to dispersed islet cells does not prevent recurrence of disease in syngeneically transplanted NOD mice. Cytokine 2000;12:405-8. Abstract

Sorensen PS, Ross C, Koch-Henriksen N, Svenson M, Skovgaard GL, Bendtzen K. Therapy-induced antibodies against interferon-beta-1a and interferon-beta-1b in patients with multiple sclerosis. Danish Multiple Sclerosis Study Group. In: Kappos L, Johnson K, Kesselring J, Radü EW, editors. Multiple Sclerosis. Tissue destruction and repair - New immunomodulating therapies. Danish Multiple Sclerosis Study Group. London: Martin Dunitz; 2000. p. 323-6.

Stylianou E, Aukrust P, Bendtzen K, Müller F, Frøland SS. Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection. Clin Exp Immunol 2000;119:479-85. Abstract

Svenson M, Hansen MB, Thomsen AR, Diamant M, Nansen A, Rieneck K, Otterness IG, Bendtzen K. Cytokine vaccination: neutralising IL-1a autoantibodies induced by immunisation with homologous IL-1a. J Immunol Meth 2000;236:1-8. Abstract.

Other publications:

Bendtzen K, Rieneck K, Bovin LF. GeneChips: En revolutionerende ny teknologi. Finsen nyt 2000;7:8-9.

This site is part of a frame. If you arrived to this page directly, click here!

2000

Written publications

Theses:
Rasmussen ÅK. Cytokine actions on the thyroid gland. Lægeforeningens Forlag. (Thesis). Univ. of Copenhagen, Copenhagen 2000. (with Div. Endocrinol., Rigshospitalet).

Bovin LF. Effekter af membranlipider og intracellulære signalmolekyler på humane leukocytter: Cytokinproduktion, celledeling og programmeret celledød (apoptose) (PhD). Univ. of Copenhagen, Copenhagen 2000.

Petersen AA. Characterisation and clinical relevance of soluble ICAM-1 in multiple sclerosis [Ph.D]. Univ. of Copenhagen, Copenhagen 2000.

Books:

Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors.
Basal og klinisk Immunologi. 3 ed. København: FADL's forlag A/S; 2000. 440 pages.

Chapters in Books:

Andersen V, Wiik A, Mandrup-Poulsen T, Nerup J, Hansen NE, Birgens H, Sørensen PS. Autoimmunsygdomme. In: Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors. Basal og Klinisk immunologi. 3 ed: FADL's forlag A/S; 2000. p. 209-54.

Andersen V, Heilmann C, Dickmeiss E. Immundefekter - AIDS. In: Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors. Basal og Klinisk immunologi. 3 ed: FADL's forlag A/S; 2000. p. 265-82.

Bendtzen K, Haurum JS, Svejgaard A, Ryder LP, Ødum N, Barington T. Celleinteraktioner og regulering. In: Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors. Basal og Klinisk immunologi. 3 ed: FADL's forlag A/S; 2000. p. 67-104.

Bendtzen K, Poulsen LK, Wiik A, Svehag S-E. Immunpatogenese og inflammation. In: Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors. Basal og Klinisk immunologi. 3 ed: FADL's forlag A/S; 2000. p. 151-84.

Bendtzen K, Andersen V, Malling H-J. Immunterapi. In: Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors. Basal og Klinisk immunologi. 3 ed: FADL's forlag A/S; 2000. p. 345-59.

Bendtzen K. Immunologiske metoder. In: Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors. Basal og Klinisk immunologi. 3 ed: FADL's forlag A/S; 2000. p. 371-405.

Werdelin O, Andersen V. Immunsystemets celler og væv. In: Bendtzen K, Marker O, Svehag S-E, Svejgaard A, Kilian M, editors. Basal og Klinisk immunologi. 3 ed: FADL's forlag A/S; 1999. p. 7-24.

Peer-reviewed articles:

Andersen LS, Petersen J, Bendtzen K. Production of interleukin (IL)-1b, IL-1 receptor antagonist and IL-10 by mononuclear cells in chronic arthritis. Cytokine 2000;12:62-8. Abstract.

Bendtzen K, Hansen MB, Ross C, Svenson M. Detection of autoantibodies to cytokines. Mol Biotechnol 2000;14:251-61 (Review). Abstract

Bendtzen K, Ross C, Hansen MB, Svenson M. Natural and induced anti-cytokine antibodies. In: Ciliberto G, Savino R, editors. Cytokine inhibitors. New York: Marcel Dekker; 2000. p. 53-95. (Review).

Garred P, Madsen HO, Marquart H, Hansen TM, Sørensen SF, Petersen J, Volck B, Svejgaard A, Graudal NA, Rudd PM, Dwek RA, Sim RB, Andersen V. Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol 2000;27:26-34.

Jess P, Schultz K, Bendtzen K, Nielsen OH. Systemic inflammatory responses during laparoscopic and open inguinal hernia repair: A randomised prospective study. Eur J Surg 2000;166:540-4.

Meyer CN, Svenson M, Larsen CS, Ødum N, Skinhøj P, Bendtzen K. Low prevalence of antibodies and other plasma factors binding to CC chemokines and IL-2 in HIV-positive patients. APMIS 2000;108:122-30. Abstract

Myhr KM, Ross C, Nyland HI, Bendtzen K, Vedeler CA. neutralising antibodies to interferon (IFN) a-2a and interferon b-1a or interferon b-1b in MS are not cross-reactive. Neurology 2000;55:1569-1571. Abstract

Nicoletti F, Di Marco R, Zaccone P, Salvaggio A, Magro G, Bendtzen K, Meroni P. Murine concanavalin A-induced hepatitis is prevented by interleukin (IL)-12 antibody and exacerbated by exogenous IL-12 through an interferon-g-dependent mechanism. Hepatology 2000;32:728-733. Abstract

Nicoletti F, Di Marco R, Conget I, Gomis R, Edwards C 3rd, Papaccio G, Bendtzen K, Sandler S. Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin. J Autoimmunity 2000;15:395-405. Abstract

Papaccio G, Nicoletti F, Pisanti FA, Bendtzen K, Galdieri M. Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells. Endocrinology 2000;141:1500-5. Abstract

Pedersen G, Saermark T, Horn T, Giese B, Bendtzen K, Brynskov J. Cytokine-induced impairment of short-chain fatty acid oxidation and viability in human colonic epithelial cells. Cytokine 2000;12:1400-1404. Abstract

Pedersen G, Saermark T, Bendtzen K, Brynskov J. Cultures of human colonic epithelial cells isolated from endoscopical biopsies from patients with inflammatory bowel disease. Effect of IFN-gamma, TNFa and IL-1b on viability, butyrate oxidation and IL-8 secretion. Autoimmunity 2000; 32:255-263. Abstract

Rasmussen ÅK, Bendtzen K, Feldt-Rasmussen U. Thyrocyte-Interleukin-1 interactions. Exp Clin Endocrinol Diabetes 2000;108:67-71 (Review). Abstract

Rieneck K, Bovin LF, Josefsen K, Buschard K, Svenson M, Bendtzen K. Massive parallel gene expression profiling of RINm5F pancreatic islet b-cells challenged with interleukin-1b. APMIS 2000;108:855-872. Abstract

Ross C, Clemmesen KM, Svenson M, Sorensen PS, Koch-Henriksen N, Skovgaard GL, Bendtzen K. Immunogenicity of interferon-beta in multiple sclerosis patients: influence of preparation, dosage, dose frequency, and route of administration. Danish Multiple Sclerosis Study Group. Ann Neurol 2000;48:706-712. Abstract

Saldeen J, Sandler S, Bendtzen K, Welsh N. Liposome-mediated transfer of IL-1 receptor antagonist gene to dispersed islet cells does not prevent recurrence of disease in syngeneically transplanted NOD mice. Cytokine 2000;12:405-8. Abstract

Sorensen PS, Ross C, Koch-Henriksen N, Svenson M, Skovgaard GL, Bendtzen K. Therapy-induced antibodies against interferon-beta-1a and interferon-beta-1b in patients with multiple sclerosis. Danish Multiple Sclerosis Study Group. In: Kappos L, Johnson K, Kesselring J, Radü EW, editors. Multiple Sclerosis. Tissue destruction and repair - New immunomodulating therapies. Danish Multiple Sclerosis Study Group. London: Martin Dunitz; 2000. p. 323-6.

Stylianou E, Aukrust P, Bendtzen K, Müller F, Frøland SS. Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection. Clin Exp Immunol 2000;119:479-85. Abstract

Svenson M, Hansen MB, Thomsen AR, Diamant M, Nansen A, Rieneck K, Otterness IG, Bendtzen K. Cytokine vaccination: neutralising IL-1a autoantibodies induced by immunisation with homologous IL-1a. J Immunol Meth 2000;236:1-8. Abstract.

Other publications:

Bendtzen K, Rieneck K, Bovin LF. GeneChips: En revolutionerende ny teknologi. Finsen nyt 2000;7:8-9.